WebDisclosure WebDisclosure
Basculer en Français
10963 Companies
239918 Keywords
168696 Articles
129079 Press releases
Headlines Articles Press releases MEDESIS PHARMA Remove
  1. Home
  2. Companies
  3. MEDESIS PHARMA
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • REGULATED PRESS RELEASE

    published on 10/11/2023 at 18:00, 2 years 10 months ago

    MEDESIS PHARMA : PUBLICATION D’UN ARTICLE SCIENTIFIQUE DANS LE JOURNAL OF ALZHEIMER’S DISEASE SUR L’UTILISATION DU LITHIUM POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER

    Logo of MEDESIS PHARMA
  • REGULATED PRESS RELEASE

    published on 10/11/2023 at 18:00, 2 years 10 months ago

    MEDESIS PHARMA: PUBLICATION OF A SCIENTIFIC ARTICLE IN THE JOURNAL OF ALZHEIMER’S DISEASE ON THE USE OF LITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE

    Logo of MEDESIS PHARMA
  • REGULATED PRESS RELEASE

    published on 10/03/2023 at 18:00, 2 years 11 months ago

    MEDESIS PHARMA RECEIVES APPROVAL FROM THE MONTPELLIER COMMERCIAL COURT TO OPEN A SAFEGUARD PROCEDURE

    Logo of MEDESIS PHARMA
  • REGULATED PRESS RELEASE

    published on 10/03/2023 at 18:00, 2 years 11 months ago

    MEDESIS PHARMA OBTIENT UN ACCORD POUR L’OUVERTURE D’UNE PROCÉDURE DE SAUVEGARDE AUPRÈS DU TRIBUNAL DE COMMERCE DE MONTPELLIER

    Logo of MEDESIS PHARMA
Previous page
1 ... 3 4
Accesswire
  • Published on 09/10/2026 at 17:46, 51 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 3 hours 17 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 3 hours 37 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

  • Published on 09/10/2026 at 14:37, 4 hours ago

    Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall

  • Published on 09/10/2026 at 14:30, 4 hours 7 minutes ago

    Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference

View all ACCESSWIRE
EQS Group
  • Published on 09/10/2026 at 18:12, 24 minutes ago

    Amundi Physical Metals plc: UK Final Terms

  • Published on 09/10/2026 at 18:10, 27 minutes ago

    Amundi Physical Metals plc: Final Terms

  • Published on 09/10/2026 at 18:00, 37 minutes ago

    ARVERNE GROUP: Arverne annonce la nomination d’un Directeur Commerce & Marketing Groupe au sein de son Comité Exécutif

  • Published on 09/10/2026 at 18:00, 37 minutes ago

    ARVERNE GROUP: Arverne announces the appointment of a Group Sales & Marketing Director to its Executive Committee

  • Published on 09/10/2026 at 18:00, 37 minutes ago

    ROCTOOL Visits CCE in Shanghai and Exhibits at CAMX in Atlanta

View all EQS
Les Echos
  • Published on 09/10/2026 at 18:10, 27 minutes ago

    LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026

  • Published on 09/10/2026 at 17:45, 52 minutes ago

    COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée

  • Published on 09/10/2026 at 17:42, 54 minutes ago

    Déclaration d'actions et de droits de vote au 31.08.2026

  • Published on 09/10/2026 at 16:01, 2 hours 35 minutes ago

    Derichebourg annonce le succès de son offre d’obligations vertes senior

  • Published on 09/10/2026 at 07:00, 11 hours 37 minutes ago

    2026 H1 results and new identity

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy